Abstract
Background/purpose
The most potent virulence factors of the periodontal pathogen Porphyromonas gingivalis are gingipains, three cysteine proteases (RgpA, RgpB, and Kgp) that bind and cleave a wide range of host proteins. Considerable proof indicates that RgpA contributes to the entire virulence of the organism and increases the risk of periodontal disease by disrupting the host immune defense and destroying the host tissue. However, the functional significance of this proteinase is incompletely understood. It is important to analyze the effect of arginine-specific gingipain A gene (rgpA) on selected virulence and physiological properties of P. gingivalis.
Materials and methods
Electroporation and homologous recombination were used to construct an rgpA mutant of P. gingivalis ATCC33277. The mutant was verified by polymerase chain reaction and sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Cell structures of the mutant were examined by transmission electron microscopy and homotypic biofilm formation was examined by confocal laser scanning microscopy.
Results
Gene analysis revealed that the rgpA gene was deleted and replaced by a drug resistance gene marker. The defect of the gene resulted in a complete loss of RgpA proteinase, a reduction of out membrane vesicles and hemagglutination, and an increase in homotypic biofilm formation.
Conclusion
Our data indicate that an rgpA gene deficient strain of P. gingivalis is successfully isolated. RgpA may have a variety of physiological and pathological roles in P. gingivalis.
Keywords: Porphyromonas gingivalis, rgpA, mutant, outer membrane vesicles, biofilm formation
Introduction
Periodontal disease is a chronic inflammatory disease involving bacteria pathogens interacting with host cells, leading to the destruction of the teeth supporting structures. The inflammation has been considered to be a result of an increasing amount of bacteria pathogens in the dental plaque. The major causative agent, Porphyromonas gingivalis, is a Gram-negative, nonmotile, asaccharolytic anaerobe.1, 2 Accumulating data suggest an association between this periodontitis organism infection and systemic inflammatory diseases such as diabetes mellitus, cardiovascular disease.3, 4 P. gingivalis possesses a variety of virulence factors including fimbriae, lipopolysaccharide, outer membrane vesicles (OMVs), and gingipains. The gingipains are trypsin-like cysteine proteases that contribute to 85% of the overall proteolytic activity and play the most significant role in its virulence.5
Gingipains are located in the culture supernatant, in the membrane surface, and within the cytoplasm. There are two kind of gingipains based on substrate specificity. Arginine-specific gingipains (Rgp) cleave peptide bonds specifically at Arg residues and lysine-specific gingipain (Kgp) cleaves peptide bonds specifically at Lys residues.6 There are two Arg-gingipains (RgpA and RgpB), encoded by two genes, rgpA and rgpB, respectively. Lys-gingipain is encoded by a single kgp gene.7 Proteinases RgpA and Kgp both consist of an N-terminal propeptide region, a proteolytic domain, and C-terminal HA domains. Their HA domains are highly homologous in sequence. However, RgpB lacks the large C-terminal HA domain.8 Depending on complex post-translational processing of the initial translation product, RgpA occurs in at least three isoforms, the initial 95 kDa polyprotein with the 50 kDa catalytic domain noncovalently associated with HA domains, the 50 kDa soluble monomeric form of RgpA secreted into extracellular environment, and 70–90 kDa glycosylation modified RgpA associated with vesicles and bacterial membranes.9, 10
Gingipains are critical to physiology of P. gingivalis. This primarily manifest in two aspects: (1) gingipains are important for generating peptides or amino acids as energy and carbon source for the organism; and (2) rgpA gene is involved in processing mechanisms for bacteria surface proteins, such as fimbrillin and Kgp. In Rgp-deficient mutants, fimbrillin remains in the precursor form and Kgp is abnormally processed.11 In addition to these physiological roles, gingipains are also used by P. gingivalis to manipulate and evade the host immune response via complex mechanisms.12, 13 It has been reported that gingipains are involved in host invasion, tissue destruction, agglutination and hemolysis of erythrocytes, and disruption and manipulation of the inflammatory response.14, 15 Proteinase RgpA especially has been shown to be a potent virulence factor in terms of proteolytic destruction of host connective-tissue proteins and disruption of host defense mechanisms.16 Rgp is implicated in immunological dysregulation and chronic inflammation by inactivating cytokines and their receptors, such as T-cell growth factor interleukin-2, anti-inflammatory cytokines interleukin-4 and interleukin-5,17 proinflammatory cytokines interleukin-12 and tumor necrosis factor-α,18 by cleaving T cell co-receptor molecules CD4, CD8,19 and by degrading complement molecules and immunoglobulins.20 Whereas the structures of gingipains are well defined in previous studies, the functional significance of rgpA is not completely understood. Unravelling the function of the P. gingivalis rgpA gene will contribute to the understanding of the mechanisms applied by this pathogen to evade host immune responses and cause disease. In this study, we provide a new method to isolate an rgpA-deficient mutant of P. gingivalis. Different from the conventional approach using recombinant plasmids, our method for gene deletion is convenient and efficient. We further characterize micromorphology of the rgpA deficient strain, and examine function of this gene in hemagglutination and homotypic biofilm formation.
Materials and methods
Bacterial strains and plasmids
P. gingivalis ATCC33277 and Escherichia coli DH5α were used. Suicide plasmid pPHU281 (provided by Professor Li, Medical School of Nanjing University, Nanjing, China) and pGEM-T-Easy Vector (Promega, Madison, WI, USA) was used to construct the suicide plasmid, which was prepared for P. gingivalis gene manipulation. Gene rgpA (PGN_1970, GeneBank: AP009380.1) and ermF-ermAM cassette (GeneBank: AF219231.1) were respectively derived from P. gingivalis genomic DNA and plasmid pVA2198.21
Culture conditions
P. gingivalis cells were grown anaerobically (10% CO2,10% H2, and 80% N2) in trypticase soy broth (TSB) medium (containing, per liter, 30 g of Tryptone Soya Broth, 1 g of yeast extract, 50 mg of hemin, and 1 mg of menadione). For blood agar plate, defibrinated sheep blood was added to Columbia blood agar plate (OXOID, Basingstoke, Hampshire, UK) at 5%. Luria–Bertani medium (containing, per liter, 10 g of tryptone, 5 g of yeast extract, and 10 g of sodium chloride) was used for E. coli cell growth. For mutant screening and genetically stability of the antibiotic-resistance strain, erythromycin (300 μg/mL for E. coli and 10 μg/mL for P. gingivalis) was added to the media. Bacterial growth was monitored by measuring the optical density at 660 nm (OD660).
Construction of plasmids and donor DNA fragment
Recombinant plasmid pPHU281_up_erm_down was constructed as follows. For construction of the rgpA-deletion cassette, the upstream (1.1 kb) and downstream (1 kb) of rgpA were amplified by polymerase chain reaction (PCR) from P. gingivalis ATCC33277 chromosomal DNA with corresponding primer pairs (upF and upR for upstream, downF and downR for downstream). Primers used in this study are listed in Table 1. The resistance gene, a 2.2 kb ermF-ermAM cassette was amplified with pVA2198 as PCR template. According to the method described by Heckman and Pease,22 the rgpA-upstream, ermF-ermAM and rgpA-downstream fragments were spliced by overlap extension to generate a full-length product, named up_erm_down (4.3 kb). The up_erm_down fragment then was cloned into vector pGEM-T Easy, resulting in plasmid pGT_up_erm_down. pGT_up_erm_down was transformed into E. coli DH5α. The positive clones were screened and propagated, and the recombinant plasmid was prepared, purified, and digested with EcoRI restriction enzyme to dissociate the fragment containing up_erm_down, which was then ligated with EcoRI linearized plasmid pPHU281 to yield a new suicide plasmid (pPHU281_up_erm_down). For efficient electroporation of P. gingivalis, a truncated DNA fragment from up_erm_down (named up_erm_down', 3.7 kb) was amplified with pGT_up_erm_down or pPHU281_up_erm_down as PCR templates. Fragment up_erm_down' is also composed of three parts—the 0.8 kb upstream, the 2.2 kb ermF-ermAM cassette and the 0.7 kb downstream in a sequential order. DNA fragment up_erm_down' and plasmid pPHU281_up_erm_down were both used as donors for electroporation of P. gingivalis.
Table 1.
Primers and sequences designed for rgpA mutant construction and genetic analysis.
Primer | Primer sequence (5′–3′) |
---|---|
upF (EcoRI) | ccgaattcGGATACGGGTTCGTCTATGTAGCGGCGGAAAAATGC |
upR | CGGAAGCTATCGGGGGTACCGTTTTTCATTTTGATG |
ermF | CATCAAAATGAAAAACGGTACCCCCGATAGCTTCCG |
ermR | CTCCGAGTCCAAGACAGAACTGCAGGTCGACTCTAG |
downF | CTAGAGTCGACCTGCAGTTCTGTCTTGGACTCGGAG |
downR (BamHI) | aaggatccTATCTATCTCATGCCGGAGGCGGAAGGTGGTAACTC |
upF' | GTGTGGCGCATCAGATATATTTTCATC |
downR' | GGACAAGCCTATGGGTCGAGGACATAAG |
RgpA F | TCCACTCAGCAATCGGTGAC |
RgpA R | CGAGCATCTTCTCACCATCC |
Electroporation of P. gingivalis
Electroporation was performed following the instructions of Current Protocols in Microbiology.23 Briefly, P. gingivalis cells from blood agar plate were incubated in 10 mL TSB medium at 37°C anaerobically overnight without agitation. The overnight culture was inoculated to 100 mL TSB medium, then incubated an additional 4 hours to obtain a final OD660 of 0.55–0.65. Afterwards, P. gingivalis cells were harvested by centrifugation, washed with the electroporation buffer (EP buffer, 10% glycerol, 1mM MgCl2, filter sterilized), and resuspended in 10 mL of the same solution. Ten microliters of pPHU281_up_erm_down plasmid DNA solution or purified up_erm_down' were mixed with 100 μL of the prepared cell suspension. The whole volume of the DNA-containing cell suspension was poured into a sterile cuvette for electroporation (Pulse cuvette with 0.2 cm electrode gap; Bio-Rad, Hercules, CA, USA). Electroporation was performed under proper experimental conditions (voltage, 2.0 kV; time constant, 5 milliseconds) with an electroporation apparatus (Gene Pulser; Bio-Rad). This procedure was carried out at 4°C. After electroporation, the cell suspension was immediately mixed with 1 mL prewarmed TSB, and incubated anaerobically at 37°C for 16 hours. Cells then were spread on Columbia blood agar plate containing 10 μg/mL erythromycin and incubated for 7–10 days. The rgpA gene was replaced by ermF-ermAM cassette via a double crossover event during bacteria chromosome replication. The mutation was confirmed by PCR analysis.
Preparation of RgpA proteinase and polyacrylamide gel electrophoresis
According to previously published protocols,24 RgpA extracts were prepared. Briefly, P. gingivalis ATCC33277 was incubated in TSB medium at 37°C under anaerobic conditions. When OD660 of P. gingivalis reached 1.0, bacteria were centrifuged at 12,000g for 45 minutes at 4°C. Culture supernatant was filtered through a 0.45-mm-pore filter (Millipore, Darmstadt, Germany) to remove residual bacteria and then mixed with precooled acetone in a 40:60 volume ratio. After constant stirring over 15 minutes at −20°C, the solution was centrifuged at 12,000g for 30 minutes at 4°C. Pellet was resuspended in the prepared buffer (150mM NaCl, 20mM Bis–Tris and 5mM CaCl2). The resuspended pellet was dialyzed overnight at 4°C in a 14,000-molecular-weight cut-off dialysis tubing versus 500 mL of the same buffer containing Aldrithiol-4 (Sigma–Aldrich, St. Louis, MO, USA). During the dialysis, there were three more changes of buffer without Aldrithiol-4. After that, preparation was centrifuged at 34,000g for 1 hour at 4°C and the resulting supernatant was concentrated in an ultracentrifugal filter (Millipore) with a 10,000-molecular-weight cut-off membrane at 4°C. The concentrated gingipain extract was clarified by centrifugation at 192,000g for 1 hour at 4°C. The samples (30 μl of extract) were then added to a solubilizing buffer and kept at 100°C for 10 minutes. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis was performed in a 1.0-mm-thick slab gel (10%). Proteins on gels were stained with Coomassie Brilliant Blue G-250.
Hemagglutination
Overnight cultures of P. gingivalis in TSB medium were centrifuged for 15 minutes (4°C, 10,000g), washed with phosphate-buffered saline (PBS), and suspended in PBS. The bacterial suspensions (OD660 = 0.4) were then diluted in a two-fold series with PBS. A 100 μL aliquot of each suspension was mixed with an equal volume of sheep erythrocyte suspension (2.5% in PBS) and incubated in a round-bottom microtiter plate at room temperature for 3 hours. The hemagglutinating activity was assessed visually.
Transmission electron microscopy
P. gingivalis cells were grown up to early stationary phase in TSB. The cell pellets were washed three times with PBS and fixed with 2.5% glutaraldehyde at 4°C for 2 hours. Then, cell pellets were fixed with 2% osmium tetroxide at 4°C for 90 minutes. The fixed cells were dehydrated in an ethanol series, embedded in 3% agar. Ultrathin sections were stained with uranyl acetate and lead citrate, and examined under a JEM-1010 electron microscope (JEOL, Tokyo, Japan).
Preparation of homotypic biofilms
The bacteria were grown in 12-well plates with a glass slip (round, 15 mm in diameter). The concentration of bacteria was adjusted by spectrophotometry after incubation for 24 hours and then standardized by dilution with PBS to 1 × 108 colony forming units/mL each. Every well was filled with 1.5 mL of fresh TSB medium, 100 μL of bacterial suspension and a glass slip. After incubation of 12 hours, the glass slip with the biofilm was harvested, gently washed with sterile PBS to remove free-floating bacteria, and fixed with 2.5% glutaraldehyde.
Confocal laser scanning microscope
The biofilms on the glass slips were incubated with FITC-ConA (Sigma) at 4°C in the dark for 2 hours. After that, the reagent was removed with the administration of 2 mL of sterile PBS three times. The biofilms were imaged with a confocal laser scanning microscope (Fluoview FV10i; Olympus, Tokyo, Japan) at a magnification of 300×.
Results
The coding sequence of rgpA was deleted and replaced by resistance gene ermF-ermAM by homologous recombination. The overall design for construction of the mutant is shown in Figure 1. The 2.2 kb ermF-ermAM cassette, the flanking DNA sequences upstream (1.1 kb) and downstream (1 kb) of rgpA were respectively amplified with corresponding primer pairs (Figure 2A). Using overlap-extension PCR, we ligated the above three DNA fragments in a sequential order and got a 4.3 kb fragment, named up_erm_down (Figure 2B). It was cloned into vector pGEM-T Easy and suicide vector pPHU281 (6.9 kb). Recombinant plasmid pPHU281_up_erm_down was digested with EcoRI (one EcoRI restriction site is located at 5′ region of primer upF, the other is located at the vector next to primer downR), resulting in two fragments, the 6.9 kb vector and the 4.3 kb up_erm_down. Agarose gel electrophoresis of digested DNA displayed the predicted bands (Figure 2C).
Figure 1.
A sketch gene map of Porphyromonas gingivalis ATCC33277 (WT) and the rgpA mutant strain (rgpA-). In the genome of mutant strain, rgpA was replaced by ermF-ermAM cassette (erm). PGN_1969 is the upstream gene and PGN_1971 the downstream gene adjacent to rgpA.
Figure 2.
Construction and verification of rgpA mutant strain. DNA products were analyzed by 1% agarose gel electrophoresis. (A) Upstream (lanes 1 and 2, ∼1.1 kb) and downstream (lanes 3 and 4, ∼1 kb) of rgpA, ermF-ermAM cassette (lanes 3 and 4, ∼2.2 kb) were respectively amplified by polymerase chain reaction. (B) Overlap extension products of the above three DNA fragments, named up_erm_down (lanes 1 and 2, ∼4.3 kb). (C) Restriction enzyme reaction was performed to identify the recombinant plasmid pPHU281_up_erm_down. pPHU281_up_erm_down was linearized by restriction enzyme SacI (lane 2, 11.2 kb), and cleaved into two fragments (lane 1, 2 bands, 6.9 kb and 4.3 kb) by EcoRI. (D) The genomic DNA of putative strain was amplified with specific primer pairs RgpA F and RgpA R. Mutant strains (lanes 1–4, no DNA band) were rgpA-deficient genotypes. (E) Genomic DNA of the putative strain was amplified with specific primer pairs upF' and ermR. It had been confirmed that ermF-ermAM cassette was inserted into the mutant strain (lane 1–4, ∼3 kb) genome at the rgpA locus. In (D) and (E), Porphyromonas gingivalis ATCC33277 (lane 5) and plasmid pPHU281_up_erm_down (lane 6) were used as negative control and positive control, respectively. M = DNA marker, bp.
DNA fragment up_erm_down' is a 3.7 kb PCR product amplified with primers upF' and downR' using pGT_up_erm_down or pPHU281_up_erm_down as template, as mentioned above. It was introduced to P. gingivalis cells by electroporation. The transformed P. gingivalis cells were spread on Columbia blood agar plate containing 10 μg/mL erythromycin, and cultured for 7 days at 37°C. To verify the genotypes of the putative mutants, genomic DNA was extracted and amplified with primers pairs RgpA F/RgpA R and upF'/ermR. Primers RgpA F and RgpA R are located on the coding sequence of rgpA. Primers upF' is the upstream primer to amplify up_erm_down' and ermR is the downstream primer to amplify the ermF-ermAM cassette. As shown, the mutants had rgpA gene deleted (Figure 2D) and rgpA was replaced by ermF-ermAM cassette (Figure 2E). The wild type P. gingivalis ATCC33277 and plasmid pPHU281_up_erm_down was used as negative control and positive control respectively. By DNA sequencing, we confirmed that the insert had no unintentional base changes. These results indicated that rgpA-deficient P. gingivalis was successfully constructed.
Extracts from culture supernatant of P. gingivalis and the rgpA mutant were subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis to verify the protein expression (Figure 3). A protein band of about 50 kDa was observed in culture supernatant of the wild type, but disappeared in the rgpA mutant. Since secretory RgpA is in soluble monomeric form with molecular mass about 50 kDa, it is most likely that the disappearance of the protein band in rgpA mutant is attributed to deficiency of rgpA gene.
Figure 3.
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis of gingipain extracts of Porphyromonas gingivalis ATCC33277 (WT) and the rgpA mutant (rgpA-) with Coomassie brilliant blue staining. M = molecular weight marker, kDa.
Visually, the mutant strain had normal pigmentation on blood agar plate (Figure 4B). P. gingivalis has the ability to agglutinate erythrocytes, which is one of the significant features of this organism. The hemagglutinating activity was attributed to HA domain structure of Rgp–Kgp complexes. Since the mutant in this study lacked the HA domain of rgpA, we determined hemagglutinating activity of the mutant cells. The mutant showed lower hemagglutinating activity than the wild type on sheep erythrocytes (Figure 4A).
Figure 4.
Hemagglutination and pigmentation of the rgpA mutant strain. (A) Hemagglutination activity. Porphyromonas gingivalis cells were grown in enriched trypticase soy broth, washed with phosphate-buffered saline, and suspended in phosphate-buffered saline at an optical density at 660 nm of 0.4. The suspension and its dilutions in a two-fold series were applied to the wells of a microtiter plate from left to right and mixed with sheep erythrocyte suspension (2.5%). (B) Colonial pigmentation. The mutant cells formed glossy roundish black colonies on blood agar plate after incubation anaerobically for 7 days. WT = wild type; rgpA- = rgpA mutant strain.
We examined cell structure of the rgpA mutant and the wild type strain by transmission electron microscopy. As shown in Figure 5, the mutant exhibited identical morphology and microstructure with the wild type, except fewer OMVs.
Figure 5.
Transmission electron micrographs of Porphyromonas gingivalis ATCC33277 (WT) and rgpA mutant (rgpA-). Bubbles on the cell surfaces indicate the presence of outer membrane vesicles (red arrows).
We examined the homotypic biofilm formation of the rgpA mutant by confocal laser scanning microscopy. FITC-ConA stained biofilms of the wild type strain and the rgpA mutant were imaged by software program FV10-ASW 2.1 Viewer (Fluoview FV10i; Olympus, Tokyo, Japan). As shown in Figure 6, homotypic biofilm formation of the rgpA mutant was markedly increased compared to that of wild type strain.
Figure 6.
Homotypic biofilm formation of Porphyromonas gingivalis ATCC33277 (WT) and rgpA mutant (rgpA-). Bacterial cells were incubated with a glass slip in trypticase soy broth for 12 hours. Homotypic biofilms developed on the glass slip were stained with FITC (green) and observed with a confocal laser scanning microscope. Representative images are shown.
Discussion
Gingipains are the primary virulence factors of Porphyromonas gingivalis, the main periodontopathogen. It is expected that inhibition of gingipain activity in vivo could prevent or slow down the progression of adult periodontitis.25 Therefore, elucidating pathogenic mechanisms of these proteolytic enzymes has important implications. The three approaches most adopted to investigate gingipains include immunization, analysis of knockout strains, and testing of specific protease inhibitors using murine models of infection or bone loss. To determine the significance of rgpA to pathogenicity of P. gingivalis, we constructed an rgpA mutant by integration of DNA fragment up_erm_down' or plasmid pPHU281_up_erm_down into the bacterium's genome. They both contain the flanking genes of rgpA and ermF-ermAM cassette and are used as donors for electroporation. Instead of enzymatic ligation, we used overlap extension PCR to get the target DNA fragment up_erm_down. It is a simple and accurate technique for mutagenesis and gene splicing. The DNA fragment was then cloned into suicide plasmid pPHU281 to get the recombinant plasmid pPHU281_up_erm_down. The truncated DNA fragment up_erm_down' or plasmid pPHU281_up_erm_down entered P. gingivalis competent cells by electroporation and integrated into the bacterial genome. Gene rgpA (5.1 kb) was replaced by resistant gene ermF-ermAM (2.2 kb) through homologous recombination. Based on our work, we find that using DNA fragment as electroporation donor is an efficient approach for gene disruption, or at least for P. gingivalis. This is manifested in two aspects. On one hand, DNA fragment is smaller in size than plasmid, which makes it easier to pass through cell membrane and reach to bacterial chromosome. On the other hand, bacterial colonies on antibiotic agar plate are mutant strains with hardly any false positives. This method improves work efficiency and saves the time of mutant screening.
P. gingivalis are black-pigmented colonies resulting from heme acquisition on cell surface. Hemoglobin from erythrocytes is captured by hemoglobin receptor protein on the cell surfaces, and digested by gingipain to yield heme and peptides.26 Heme and peptides transfer into bacteria to be used as nutrients. It has been postulated that heme acquisition is a defense mechanism of P. gingivalis against reactive oxygen species in the oral inflammatory microenvironment and a mechanism for iron storage.27 Gingipains Kgp and RgpA are involved in hemin acquisition, binding and accumulation of P. gingivalis, and Kgp is apparently the primary enzyme involved in binding of hemoglobin and bleeding.28 In our study, the rgpA mutant strain is black pigmented, with no difference with the wild type. This may suggest that rgpA gene plays little role in heme acquisition.
Hemagglutination is a distinctive property of P. gingivalis, and differentiates the microorganism from other asaccharolytic black-pigmented anaerobic bacteria such as Porphyromonas asaccharolytica and Porphyromonas endodontalis. Erythrocytes are the largest reserves of heme and iron. For nutrient acquisition, P. gingivalis first efficiently agglutinates erythrocytes and then slowly lyses them to release hemoglobin.29 It has been indicated that hemagglutination of P. gingivalis is caused by the rgpA-, kgp-, and hagA-encoding HA domains.13, 30 The HA subunits of RgpA consist of four sequence-related adhesion domains, Rgp15, Rgp17, Rgp27, and Rgp44. Extensive studies have been carried out to identify the hemagglutination motifs within the gingipain amino acid sequences. The peptide G907-T931 of RgpA from P. gingivalis W83 was recognized as being hemagglutination associated by monoclonal antibody MAb61BG1.3.31 The small peptide PVQNLT or PVKNLK within the G907-T931 sequence was verified as a hemagglutinion-associated short motif. This short motif is located at the C-terminus end of RgpA proteolytic domain, in the Rgp44 and Rgp17 regions.32 Sakai et al33 reported that a recombinant protein Rgp44 was able to bind to the erythrocyte membrane protein, glycophorin A. Considering that homologous sequences are found at multiple loci in the P. gingivalis genome, HA domains are supposed to have a variety of pathogenic activities.
Gingipains are produced as secreted or membrane-associated forms on the cell surface.34 Cell-associated gingipains comprise the majority (80%) of Rgp and Kgp activities. Since RgpA are mostly located on the outer membrane of P. gingivalis, inactivation of rgpA may modify cell surface properties. Surface microstructures of the rgpA mutant and P. gingivalis were examined by transmission electron microscopy. The rgpA mutant presents decreased OMVs compared with the wild type. OMVs are spherical, microstructural bodies on or around the surface of bacterial cells. They range from 20 nm to 250 nm in diameter and consist of outer membrane and encapsulated periplasmic components. As a vehicle for antigens and active proteases, OMVs of P. gingivalis carry a wide range of toxic substances such as lipopolysaccharide, gingipain, hemagglutin, carboxypeptidase, peptidylarginine deiminase, hemin-binding protein, and fimbrial protein.35 These substances are considered to be released into the crevicular environment, which play potential roles in host immune disorder and tissue destruction during P. gingivalis infection. About 17% of Rgp and 7% of Kgp were located in OMVs. The rgpA mutant expressed reduced OMVs. This may result in decreased virulence of P. gingivalis. The fimbriation of the mutant had no difference with the wild type. It has been reported that there is little or no fimbriation on the cell surface of rpgA rgpB double mutant, whereas the number of fimbriae of the rgpA or rgpB mutant is similar to the parent strain.36 The major component of fimbriae, fimbrilin, remained in the precursor form only in the rgpA rgpB double knockout strains.11 These indicate that a combination of RgpA and RgpB may affect maturation of fimbriae. However, the interaction of RgpA proteinase and the vesicles, fimbriation needs to be further studied.
Biofilm formation is related to the bacterial cell surface. Recent findings indicate that gingipains are involved in both homotypic (monospecies) biofilm formation by P. gingivalis, but also synergistic biofilm formation with other bacteria such as Fusobacterium nucleatum.34 Cranberry constituents, which are inhibitors of P. gingivalis proteinases, can prevent P. gingivalis biofilm formation.37 An iron-binding glycoprotein, lactoferrin displays biofilm inhibition activity against P. gingivalis, and the antibiofilm effect is attributable to its antigingipain activity.38 We first evaluated the roles of rgpA in homotypic biofilm formation in this study. When cultured in TSB medium for 12 hours, wild type formed biofilms with dispersed and sparser microcolonies. The mutant developed clustered, increased biofilm. Thus, rgpA seems to be a negative regulator of biofilm formation. Consistent with our results, Kuboniwa and colleagues39 found that the biovolumes of homotypic biofilms were significantly increased in rgp mutant or kgp mutant in the early maturation phase, as compared to the wild type. This negative regulation of rgpA may be essential for the initiation and maturity of biofilms. Biofilm development is in dynamic changes that both stimulative and restrictive factors act synergistically. The rgpA mutant in our study exhibited reduced out membrane vesicles. It is presumed that rgpA defection and the resulted downstream changes of bacterial cell surface may be related to the increased biofilm development.
Conflicts of interest
The authors have no conflicts of interest relevant to this article.
Acknowledgments
We appreciate the guidance of Professor Huang (Department of Biochemistry and Molecular Biology, Jiangsu University, Zhenjiang, China) for construction of rgpA-mutant. This work was supported by the National Natural Science Foundation of China (81271155, 51472115, 81300852), Key Project supported by Medical Science and Technology Development Foundation, Department of Health, Medical School of Nanjing University (ZKX13050).
References
- 1.Slots J., Genco R.J. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res. 1984;63:412–421. doi: 10.1177/00220345840630031101. [DOI] [PubMed] [Google Scholar]
- 2.Shi Y., Kong W., Nakayama K. Human lactoferrin binds and removes the hemoglobin receptor protein of the periodontopathogen Porphyromonas gingivalis. J Biol Chem. 2000;275:30002–30008. doi: 10.1074/jbc.M001518200. [DOI] [PubMed] [Google Scholar]
- 3.Maekawa T., Takahashi N., Tabeta K. Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS ONE. 2011;6:e20240. doi: 10.1371/journal.pone.0020240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yang J., Wu J., Liu Y. Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerosis patients. PLoS ONE. 2014;9:e86599. doi: 10.1371/journal.pone.0086599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Potempa J., Pike R., Travis J. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun. 1995;63:1176–1182. doi: 10.1128/iai.63.4.1176-1182.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pike R., McGraw W., Potempa J., Travis J. Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem. 1994;269:406–411. [PubMed] [Google Scholar]
- 7.Yongqing T., Potempa J., Pike R.N., Wijeyewickrema L.C. The lysine-specific gingipain of Porphyromonas gingivalis: importance to pathogenicity and potential strategies for inhibition. Adv Exp Med Biol. 2011;712:15–29. doi: 10.1007/978-1-4419-8414-2_2. [DOI] [PubMed] [Google Scholar]
- 8.Li N., Collyer C.A. Gingipains from Porphyromonas gingivalis—complex domain structures confer diverse functions. Eur J Microbiol Immunol (Bp) 2011;1:41–58. doi: 10.1556/EuJMI.1.2011.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rangarajan M., Smith S.J., U S, Curtis M.A. Biochemical characterization of the arginine-specific proteases of Porphyromonas gingivalis W50 suggests a common precursor. Biochem J. 1997;323:701–709. doi: 10.1042/bj3230701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fitzpatrick R.E., Wijeyewickrema L.C., Pike R.N. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol. 2009;4:471–487. doi: 10.2217/fmb.09.18. [DOI] [PubMed] [Google Scholar]
- 11.Kadowaki T., Nakayama K., Yoshimura F., Okamoto K., Abe N., Yamamoto K. Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis. J Biol Chem. 1998;273:29072–29076. doi: 10.1074/jbc.273.44.29072. [DOI] [PubMed] [Google Scholar]
- 12.Bittner-Eddy P.D., Fischer L.A., Costalonga M. Identification of gingipain-specific I-A(b)-restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice. Mol Oral Microbiol. 2013;28:452–466. doi: 10.1111/omi.12038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Grenier D., Roy S., Chandad F. Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis. Infect Immun. 2003;71:4742–4748. doi: 10.1128/IAI.71.8.4742-4748.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Stathopoulou P.G., Benakanakere M.R., Galicia J.C., Kinane D.F. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol. 2009;24:11–17. doi: 10.1111/j.1399-302X.2008.00467.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Andrian E., Grenier D., Rouabhia M. Porphyromonas gingivalis gingipains mediate the shedding of syndecan-1 from the surface of gingival epithelial cells. Oral Microbiol Immunol. 2006;21:123–128. doi: 10.1111/j.1399-302X.2006.00248.x. [DOI] [PubMed] [Google Scholar]
- 16.Takii R., Kadowaki T., Baba A., Tsukuba T., Yamamoto K. A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems. Infect Immun. 2005;73:883–893. doi: 10.1128/IAI.73.2.883-893.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tam V., O'Brien-Simpson N.M., Chen Y.Y., Sanderson C.J., Kinnear B., Reynolds E.C. The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis inactivate the Th2 cytokines interleukin-4 and interleukin-5. Infect Immun. 2009;77:1451–1458. doi: 10.1128/IAI.01377-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yun P.L., Decarlo A.A., Collyer C., Hunter N. Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun. 2001;69:5650–5660. doi: 10.1128/IAI.69.9.5650-5660.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kitamura Y., Matono S., Aida Y., Hirofuji T., Maeda K. Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J Periodontal Res. 2002;37:464–468. doi: 10.1034/j.1600-0765.2002.01364.x. [DOI] [PubMed] [Google Scholar]
- 20.Popadiak K., Potempa J., Riesbeck K., Blom A.M. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol. 2007;178:7242–7250. doi: 10.4049/jimmunol.178.11.7242. [DOI] [PubMed] [Google Scholar]
- 21.Fletcher H.M., Schenkein H.A., Morgan R.M., Bailey K.A., Berry C.R., Macrina F.L. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect Immun. 1995;63:1521–1528. doi: 10.1128/iai.63.4.1521-1528.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Heckman K.L., Pease L.R. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat Protoc. 2007;2:924–932. doi: 10.1038/nprot.2007.132. [DOI] [PubMed] [Google Scholar]
- 23.Belanger M., Rodrigues P., Progulske-Fox A. Wiley; New York: 2007. Genetic manipulation of Porphyromonas gingivalis. [DOI] [PubMed] [Google Scholar]
- 24.Sheets S.M., Potempa J., Travis J., Casiano C.A., Fletcher H.M. Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect Immun. 2005;73:1543–1552. doi: 10.1128/IAI.73.3.1543-1552.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kadowaki T., Baba A., Abe N. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol Pharmacol. 2004;66:1599–1606. doi: 10.1124/mol.104.004366. [DOI] [PubMed] [Google Scholar]
- 26.Nakayama K., Ratnayake D.B., Tsukuba T., Kadowaki T., Yamamoto K., Fujimura S. Haemoglobin receptor protein is intragenically encoded by the cysteine proteinase-encoding genes and the haemagglutinin-encoding gene of Porphyromonas gingivalis. Mol Microbiol. 1998;27:51–61. doi: 10.1046/j.1365-2958.1998.00656.x. [DOI] [PubMed] [Google Scholar]
- 27.Sheets S.M., Robles-Price A.G., McKenzie R.M., Casiano C.A., Fletcher H.M. Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis. Front Biosci. 2008;13:3215–3238. doi: 10.2741/2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lewis J.P., Dawson J.A., Hannis J.C., Muddiman D., Macrina F.L. Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J Bacteriol. 1999;181:4905–4913. doi: 10.1128/jb.181.16.4905-4913.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nakayama K. Porphyromonas gingivalis cell-induced hemagglutination and platelet aggregation. Periodontol 2000. 2010;54:45–52. doi: 10.1111/j.1600-0757.2010.00351.x. [DOI] [PubMed] [Google Scholar]
- 30.Shi Y., Ratnayake D.B., Okamoto K., Abe N., Yamamoto K., Nakayama K. Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA. J Biol Chem. 1999;274:17955–17960. doi: 10.1074/jbc.274.25.17955. [DOI] [PubMed] [Google Scholar]
- 31.Curtis M.A., Aduse-Opoku J., Slaney J.M. Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products. Infect Immun. 1996;64:2532–2539. doi: 10.1128/iai.64.7.2532-2539.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Shibata Y., Hayakawa M., Takiguchi H., Shiroza T., Abiko Y. Determination and characterization of the hemagglutinin-associated short motifs found in Porphyromonas gingivalis multiple gene products. J Biol Chem. 1999;274:5012–5020. doi: 10.1074/jbc.274.8.5012. [DOI] [PubMed] [Google Scholar]
- 33.Sakai E., Naito M., Sato K. Construction of recombinant hemagglutinin derived from the gingipain-encoding gene of Porphyromonas gingivalis, identification of its target protein on erythrocytes, and inhibition of hemagglutination by an interdomain regional peptide. J Bacteriol. 2007;189:3977–3986. doi: 10.1128/JB.01691-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Oishi S., Miyashita M., Kiso A. Cellular locations of proteinases and association with vesicles in Porphyromonas gingivalis. Eur J Med Res. 2010;15:397–402. doi: 10.1186/2047-783X-15-9-397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nakao R., Takashiba S., Kosono S. Effect of Porphyromonas gingivalis outer membrane vesicles on gingipain-mediated detachment of cultured oral epithelial cells and immune responses. Microbes Infect. 2014;16:6–16. doi: 10.1016/j.micinf.2013.10.005. [DOI] [PubMed] [Google Scholar]
- 36.Nakayama K., Yoshimura F., Kadowaki T., Yamamoto K. Involvement of arginine-specific cysteine proteinase (Arg-gingipain) in fimbriation of Porphyromonas gingivalis. J Bacteriol. 1996;178:2818–2824. doi: 10.1128/jb.178.10.2818-2824.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Labrecque J., Bodet C., Chandad F., Grenier D. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother. 2006;58:439–443. doi: 10.1093/jac/dkl220. [DOI] [PubMed] [Google Scholar]
- 38.Dashper S.G., Pan Y., Veith P.D. Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity. Antimicrob Agents Chemother. 2012;56:1548–1556. doi: 10.1128/AAC.05100-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Kuboniwa M., Amano A., Hashino E. Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis. BMC Microbiology. 2009;9:105. doi: 10.1186/1471-2180-9-105. [DOI] [PMC free article] [PubMed] [Google Scholar]